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Summary
This review shows that, compared to both DXA and axial QCT,
pQCT is a more versatile technique, allowing for selective as-
sessment of trabecular and cortical bone components, accu-
rate assessment of bone geometry, assessment of muscle
mass and muscle/bone relationships. Although pQCT has not
been evaluated as thoroughly as DXA in clinical research, re-
cent studies on representative populations in the USA and
Italy have yielded normative data on trabecular and cortical
bone volumetric BMD, and geometry parameters obtained by
pQCT at multiple skeletal sites. These data can be used as ref-
erence values by physicians to detect patients with osteope-
nia, assess their bone strength, and to plan appropriate,
patho-physiologically based treatment. 
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Introduction
Osteoporosis is defined as a condition characterized by re-
duced bone strength and high propensity to fractures. There-
fore, diagnosing osteoporosis implies the capacity to detect re-
duced bone strength (fragility). Age-associated decline in bone
mass is usually considered responsible for the development of
bone fragility and the consequent high rate of bone fractures
experienced by older persons. Accordingly, current guidelines
suggest that in clinical practice, the risk of fractures should be
estimated by measuring bone mineral density (BMD) by dual-
energy X-ray absorptiometry (DXA). Therefore, DXA has been
increasingly used by clinicians to diagnose osteoporosis and
estimate the risk of future fragility fractures, using an algorithm
based on T-scores, developed by the WHO study group in
1997 (1). Recommendations to use DXA as the standard
method to diagnose osteoporosis and estimate fracture risk are
based on the assumption that BMD is a good measure of bone
mass and strength. 
However, this assumption has proven incorrect. In fact, a num-
ber of recent reports have argued that DXA is insensitive to
changes in the quantitative and geometrical distribution of tra-
becular and cortical bone tissues which are important factors
affecting bone strength in both the appendicular and axial
skeleton. Moreover, DXA measurements are affected by sever-
al sources of inaccuracy that limit the interpretability of its re-
sults (2-8). For these reasons, alternative methods to DXA
have been developed, including axial and peripheral QCT. 
Determinants of bone strength: basic concepts
In general, the strength of a given structure is determined by the
following: properties, amount and distribution of the constituent
material. In fact, the strength of the bone constituent material
(material strength) closely interacts with the architecture of the
whole bone, which is determined by the size of the bone and
the distribution of bone material. Only the evaluation of both the
material properties and the architecture, and not either of the
two alone, allows to predict if a bone subjected to a certain load
will break. The mechanical testing of a structure is performed by
the incremental application of force (compressive, tensile, or
bending force) and recording its deformation on a load-deforma-
tion curve (9, 10). The force at which the structure breaks is
called the breaking strength or the ultimate strength of the struc-
ture. The area under the curve describes the capacity of the
structure to absorb energy and is called the work at failure. In
order to obtain information on material strength, both the force
and the deformation are divided by the cross-sectional area of
the structure; a stress-strain curve is so obtained, where stress
(whose unit is the Pascal) is force (in Newton) per unit area (in
square meter) and strain is the ratio of the deformation by the
initial length. The slope of the linear part of the stress-strain
curve represents the modulus of elasticity (E) of the material (al-
so called the material stiffness), the stress at fracture is called
the ultimate stress or breaking strength of the material, and the
area under the curve describes the toughness of the material or
the capacity of the material to absorb energy before breaking.
The described mechanical testing can be performed in humans
only on excised bones and constitutes the benchmark against
which the methods for non-invasive estimation of bone strength
are validated. Material stiffness (or modulus of elasticity) and
material toughness are the main properties describing the
strength of bone material. The modulus of elasticity is influ-
enced by the porosity and the degree of mineralization of the
bone tissue. On the other hand, toughness (the opposite of
tough is brittle) is probably also substantially influenced by bone
matrix and collagen structure (11). 
Structural strength, as described by the load-deformation
curve, will be determined by the material strength and by the
architecture (or geometry) of the examined structure. However,
the resistance against different types of loads is determined by
different geometric characteristics and must be evaluated sep-
arately (10). The determinants of compressive strength are the
modulus of elasticity and the cross-sectional area (the relative
formula is: E*A, where E is the stiffness, and A is the cross-
sectional area). Thus, bone size is a simple geometric factor in-
fluencing compressive strength; a bigger bone is stronger than
a smaller bone in compression. Resistance against bending
and torsional loads, on the other hand, is determined more by
the distribution of the material than by size itself. The most im-
portant geometric component of the resistance against bending
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(and torsion) is the moment of inertia, critically determined by
the distance of the material from the plane of bending. The rel-
evant formula for the determination of bending and torsional
strength is therefore: E*I, where I is the moment of inertia. This
concept is important for the estimation of appendicular bone
strength, including hip; in fact, the age-related bone loss, lead-
ing to thinning of the cortex of long bones, and potentially to a
dramatic decrease in strength, is compensated for by the in-
crease in periosteal diameter. With this putative adaptative
mechanism bone material is displaced away from the central
axis and as a consequence the decrease in the moment of in-
ertia with its attendant loss in bending and torsional strength is
prevented (12, 13). There is some evidence of a sexual dimor-
phism in this mechanism which may, at least in part, account
for the greater propensity of older women to undergo fragility
fractures (14).
The role of microarchitecture in determining the compressive
strength of the trabecular bone has been emphasized in recent
years, although controversies on the importance of this factor
still exist. 
Limitations of DXA 
As mentioned in the introduction, DXA has inherent limitations
that preclude accurate assessments of bone strength. The fol-
lowing is a brief overview of the most critical points which raise
serious concerns about the use of the so-called areal BMD as
a measure of bone strength. 
1. The most obvious source of inaccuracy is inherent in the cal-
culation of areal BMD as BMC/bone area. Bone area, and
hence size, is a positive determinant of bone strength, both in
compression and in bending or torsion. Therefore, persons
with higher bone area have higher bone strength, compared
with persons with the same BMC and smaller bones, but DXA
would assign them a lower BMD value. This limitation applies
to comparisons between individuals of different stature and
bone size, because of different race, gender, age, or exposition
to anabolic agents (such as teriparatide). As pointed out in a
recent editorial, BMC, not BMD should be used in these cir-
cumstances as a proxy measure of bone strength (Heaney OI,
2005). However, data from a large survey in healthy women in-
dicate a 1.12 difference in spine BMC Z-score between individ-
uals belonging to the extreme quintiles for stature (8).
2. A second reason why BMD and BMC are inaccurate in as-
sessing bone strength is the influence on measurement by the
composition of the soft tissue surrounding the bone. In fact, a
large number of ex vivo and in vitro experiments show that DXA
is inherently inaccurate because it operates with two x-ray ener-
gies while the human body is composed of three main types of
tissues: bone, muscle, and fat. This so called two-component
limitation can lead to an underestimate of bone density as high
as 60%, particularly in frail older women with low bone mass, a
low percentage of body fat, and fatty bone marrow. It should be
noted that the above-mentioned source of inaccuracy is inherent
to the DXA technology; therefore, it does not pertain to incorrect
use of instrumentation, incorrect positioning, or conditions relat-
ed to the examined subject (obesity, extra-skeletal calcifications)
which would further increase the probability of measurement er-
rors (2-7). As a consequence of the above, longitudinal assess-
ments of BMC/BMD are also flawed if body composition
changes in a given individual, for example because of body
weight loss following diet, exercise, or disease. 
3. Even assuming that BMC accurately assesses bone mass, it
should be noted that bone mass is not itself a satisfactory predic-
tor of bone compressive strength, In fact, compressive strength
depends not only on bone mass but also on bone size. This con-
cept is easier to understand if we compare two bones with the
same bone mass; one has a very high apparent density and is
small, while the other has a wider section and a lower apparent
density. The latter bone can resist better compressive loads al-
though the BMC reading of the device will be the same. 
4. If BMC and BMD have limitations in predicting compressive
strength, they give no information on bending or torsional
strength or, worse, they provide misleading results. In fact,
bending and torsional strength are related to bone size and
distribution of bone material within the bone (bone geometry),
structural characteristics that are best described by moments
of inertia (or by section moduli in non-cylindrical bones), rather
than bone mass. As mentioned above, DXA measures bone
mass but not moments of inertia or section moduli, that is bone
geometry. Several lines of research suggest that, over the ag-
ing process, the bone tissue goes through a remodelling
process mostly involving an enlargement of the cortical bone
“ring”. Although this remodelling process increases the bone
mechanical resistance to fractures (8), it is detected by DXA
simply as a reduction in BMD. Indeed, since most epidemiolog-
ical studies on the aging bone were based on DXA measures,
very little is known about the dynamics of cortical bone mass in
growth and aging.
The contribution of axial Quantitative Computed Tomography
(QCT) to osteoporosis diagnosis and clinical research
Currently, the standard diagnosis of osteoporosis is based on
the assessment of bone mineral density performed with DXA.
Although this method is widely used in both clinical and re-
search settings, it has some important limitations, as outlined
above. In order to circumvent these problems, alternative
methods for assessing bone strength have been proposed, in-
cluding Quantitative Computed Tomography (QCT) of the axial
and peripheral skeleton. QCT allows for separate assessments
of cortical and trabecular bone and provides direct information
on bone geometry. 
Axial QCT has been used most commonly at the spine level for
assessment of apparent volumetric density of trabecular bone.
The main theoretical advantage of QCT over DXA is the exclu-
sion from the measurement of structures that do not contribute
to spine mechanical resistance, yet contribute to DXA BMD val-
ues, and the possibility to selectively measure trabecular tissue,
considered to be the main determinant of compressive strength
in the vertebrae. Indeed, QCT measurements of spinal trabecu-
lar volumetric BMD (vBMD) are strongly associated with verte-
bral fractures; in this respect, its discriminatory capability be-
tween fractured and non-fractured subjects is greater than either
antero-posterior and lateral DXA (15, 16). Spinal QCT has, how-
ever, several disadvantages which have limited its widespread
application. First, the relatively high radiation dose to patients
limits its use for repeated measurements, especially in children.
Second, the cortical shell in the vertebrae is too thin to be accu-
rately assessed by QCT, however a few reports have stressed
the importance of cortical bone in the vertebrae: trabecular bone
loss is a universal phenomenon, but vertebral fractures occur
only when cortical bone is also compromised (17). Third, in spite
of a good accuracy in the diagnosis of osteoporosis and in the
prediction of fracture risk, spine QCT has a poor precision that
limits its applicability to longitudinal assessments. Fourth, the
use of CT scanners for densitometry purposes is hindered by
several factors, including the high cost, a high degree of opera-
tor dependence, space requirement, and limited access to the
scanners. Axial QCT has been used only for the assessment of
spine vBMD because the complexity of the hip architecture has
precluded the development of reliable methods for densitometric
114 Clinical Cases in Mineral and Bone Metabolism 2005; 2(2): 113-118
C.R. Russo
PERIPHER L_Russo  25/10/2005  11.43  Pagina 114
assessment in this clinically important region. 
In spite of all these limitations, spine and hip QCT have con-
tributed important information regarding the role of trabecular
bone loss and differences in bone size in predicting fracture
risk during the aging process and in specific diseases (18).
In conclusion, axial QCT has provided interesting contributions
to osteoporosis research but it has gained limited acceptance
in clinical applications because of convenience problems such
as costs, availability, and irradiation risks, as well as technical
limitations, including poor precision, limitation in the assess-
ment of cortical bone, and difficulty to assess bone geometry
because of anatomical constraints.  
Peripheral QCT (pQCT) as a mean to diagnose osteoporosis
and obtain a reliable assessment of bone strength 
and fracture risk 
In order to obviate the limitations of DXA and axial QCT, a pe-
ripheral quantitative computed tomography (pQCT) device has
been developed, which allows for separate assessments of
cortical and trabecular bone and provides direct information on
bone geometry at several appendicular bone sites. From the
analysis of cross-sectional images provided by pQCT, informa-
tion on mass and distribution of bone material can be integrat-
ed into indexes of bone stability in response to bending and
torsional loads, which are the two most important biomechani-
cal measures of susceptibly to fracture and may improve our
accuracy in the prediction of fractures (10).
Development and technical characteristics of pQCT
pQCT was developed as a result of the concomitant pioneering
efforts in the early 1980s by Schneider and coworkers in
Wurzburg, Germany, and Ruegsegger and coworkers in Switzer-
land. Early pQCT devices were designed by the Stratec Compa-
ny in Germany with the cooperation of the University of
Wurzburg, and by the Swiss Company Scanco Medical. While
both companies developed and commercialized newer genera-
tion, reliable pQCT devices, only the devices produced by Stratec
achieved a wide diffusion due to lower cost (19). The Stratec de-
vices XCT 900 and XCT 960 for clinical use, and XCT 960 A for
research purpose in small animals utilized an X-ray tube with ap-
propriate filtering and collimating systems, which resulted in high-
er image resolution and shorter scanning times. The only differ-
ence between XCT 900 and XCT 960 is a different calibration.
The basic technical characteristics of Stratec pQCT devices in-
clude the translate-rotate technique and a multidetector system
for different acquisition angles. Moreover, energy dispersion due
to the “beam hardening effect”, that is the energy absorption by
soft tissues surrounding bones, is successfully corrected by a
pre-processing system, based on aluminum step phantoms. For
image reconstruction, the Shepp and Logan backprojection algo-
rithm is used. The pQCT devices deliver a radiation exposure to
the patients < 0.1 µSv. The reported precision of XCT 900 and
XCT 960 in vivo for trabecular density is 1-2% (19).
In the late 1990s Stratec released a new generation device,
XCT 2000 (and XCT 3000, having a wider gantry), which is
now widely diffused in North America, Asia, and in Europe.
XCT 2000 provides a better image resolution than the 900 se-
ries, ranging from 0.02 to 0.5 mm, using variable matrix sizes
of up to 400 x 400, and shorter scan times. The main technical
characteristics of the XCT 2000 are shown in Table I (22). In vi-
vo precision figures for the XCT 2000 are greatly improved
over the 900 series ranging from about 0.8% for trabecular
density, to less than 0.5% for bone cross-sectional areas. On
the other hand, the calculation of more complex parameters,
such as moments of inertia, imply a lower precision (CV about
1-3%) (20, 21). The XCT 2000 is designed to perform multislice
measurements at the forearm and the lower leg and, with ap-
propriate softwares, can assess muscle cross-sectional area at
both measurement sites (22).
Research and clinical applications of pQCT 
The first applications of pQCT devices in both experimental an-
imals and humans was to obtain a selective measure of volu-
metric density of trabecular tissue at radial metaphysis. Later,
the use of pQCT was extended to include the assessment of
cortical bone volumetric density, cortical bone cross-sectional
area, and whole bone stability parameters such as moments of
inertia and section moduli. Following is a brief overview of the
biomechanical meaning and the potential clinical usefulness of
these parameters, as well as the problems associated with
their interpretation in both the research and the clinical setting. 
Introduction to QCT procedures
For the reader not accustomed to QCT measurements, I would
like to briefly introduce the basic procedures leading from the
reconstructed CT image to the calculation of bone parameters.
The first step is to establish, empirically, a threshold density
value that provides the best discrimination between tissues.
For instance, the external bone contour is sometimes obtained
introducing a threshold value of 240 mg/cm3; the contour of the
bone is obtained by excluding (using an appropriate algorithm)
from the image all the voxels having a density lower than 240
mg/cm3, and presumed to belong to soft tissue surrounding
bone. In the case of very osteoporotic bones, however, a lower
threshold (180 mg/cm3) will exclude equally well all soft tis-
sues, and will include more reliably the whole bone boundary.
Using similar procedures at the metaphysis, a threshold of 430
mg/cm3 can be applied to the interface between cortical and
trabecular bone, in order to separate the two tissues; alterna-
tively, or as an adjunctive conservative measure, the operator
may decide to accept as “pure” trabecular bone only the inner
Clinical Cases in Mineral and Bone Metabolism 2005; 2(2): 113-118 115
Peripheral CT in the diagnosis of osteoporosis
Table I - Technical characteristics of the pQCT device XCT 2000 (22).
Slice thickness (mm) 2.3 High voltage (KV) 56-60
Voxel size (mm) 0.2-0.8 Anode Current (µA) < 300
Gantry opening (mm) 140 Radiation dose CT scan (mSv) 0.03
Weight (kg) 45 Scan time (radius) (sec) 90
Dimensions (cm) 55*93*62 Max movement in Z (mm) 230
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45% of the cross-sectional area (CSA) of bone. At the radial or
tibial diaphysis, where trabecular bone is not represented, a
threshold of 710 mg/cm3 is ideal to separate medullary area
from the cortical tissue. Once the tissues are separated as de-
scribed, an algorythm “counts” the voxels belonging to the tis-
sue of interest and provides the CSA for that specific tissue or,
if vBMD is the parameter of interest, provides the average den-
sity value of those voxels. These procedures have been con-
sistently shown to be reliable and accurate (23).
Assessment of trabecular bone
This was an obvious extension of the axial QCT. The practical
advantage of pQCT over axial QCT was to make volumetric
bone density (vBMD), a measure independent from body size,
widely available to researchers and clinicians. It should be noted
that QCT-measured volumetric density is a tissue density, there-
fore an apparent density, not a material density. This means that
bone marrow is included in the measurement and that the mea-
sure is actually the average of the density of voxels containing
bone marrow and those containing trabeculae, and as such it is
similar to the histomorphometry parameter BV/TV. This said, tra-
becular vBMD is usually assessed at the distal metaphysis of ra-
dius and tibia (other potential measurement sites are proximal
tibia, proximal radius, distal femur) where trabecular tissue is
abundant and shows the typical rapid changes following
menopause, aging, endocrino-metabolic diseases, or terapeuti-
cal intervention with antiresorptive agents. 
Many studies in animals have exploited these features, particularly
the rapidity of response, which allowed shorter duration of experi-
ments and greater sensitivity compared to DXA (24). For instance,
trabecular vBMD decline is significant within 1-2 weeks after
ovariectomy in rats, compared with a lag of several weeks if DXA
areal BMD is used (24). Studies in humans have demonstrated
that age-related bone loss is similar for the trabecular tissue of axi-
al and appendicular skeleton (25). These studies have also shown
that in women, trabecular bone loss begins well before
menopause and continues throughout life; a similar life-long de-
cline in trabecular bone density has been reported in men, albeit
with a smaller slope (14). These studies, as well as other studies
focused on cortical bone, have substantially contributed to dis-
pelling the notion of the existence of a prolonged period of bone
stability after the achievement of peak bone mass. Rather, we now
know that “aging” of the bone begins as soon as growth ceases. 
A European multicenter study with a cross-sectional design
(the BME-COMAC study) has compared the sensitivity of tra-
becular vBMD at spine and distal radius, and areal BMD at the
spine to predict vertebral and hip fractures. ROC curves
showed that radial pQCT performed as well as spinal QCT and
DXA (areas 0.85 vs 0.84) for vertebral fractures and also pre-
dicted hip fractures. The authors of the study conclude that
pQCT should be the method of choice when evaluating gener-
alized bone loss (26). In another study with cross-sectional de-
sign, spinal X-ray was obtained in 621 postmenopausal women
to verify if a low trabecular vBMD of the radius could predict
vertebral fractures. Using a cut-off threshold of 105 mg/cm3,
the odds ratio for the association with vertebral fracture was
2.17 (95% CI: 1.69-2.77) in a receiver operating characteristic
analysis, and the area under the curve was 0.699 ± 0.023, sim-
ilar to that obtained using spinal DXA (27). In a comparison be-
tween different techniques, spine QCT showed the highest OR
for spine fractures (5.3; CI:3.6-8.3), followed by a radial pQCT
geometry parameter (5.2; CI:2.8-12.4), spinal DXA (4.8; CI:3.7-
6.1), radial trabecular vBMD by pQCT (3.2; CI:2.7-3.8), and ul-
tradistal radial DXA (2.1; CI:1.7-2.4) (28). 
Taken together, these studies suggest that trabecular vBMD at
radius is as effective as axial DXA to detect generalized osteo-
porosis and predict fracture risk. 
At radial and tibial metaphyses pQCT also measures total
bone apparent vBMD, that includes trabecular and cortical
bone and can be considered a good measure of compressive
strength, similar to the areal BMD obtained by DXA.
Rationale for cortical bone assessment, and related technical
limitations of QCT 
Early research in the osteoporosis field focused on trabecular
bone because of its sensitivity to endocrino-metabolic and ther-
apeutic influences; accordingly it was felt that densitometry
should capture trabecular bone characteristics in order to be
useful in the diagnosis and follow-up of menopause-, disease-,
and interventions-related bone changes. Consistently, spine
and hip, both containing substantial amounts of trabecular
bone, became the preferred measurement sites for DXA. 
The important contribution of cortical bone to bone mechanical
resistance is increasingly recognized. However, as also noted for
spine QCT, cortical bone cannot be assessed accurately at the
radial metaphysis, since in this site the cortical shell is so thin that
the partial volume effect inflates the magnitude of random error in
the measure. This partial volume error occurs whenever a voxel
is comprised of both cortical bone and surrounding tissues having
lower densities; in this case the algorithm assignes that voxel a
value that is intermediate between the two tissues, thus yielding
an underestimate of the true value. Since these “border voxels”
are located along the external and internal cortical boundaries,
the thinner the cortical ring, the greater the proportion of “border
voxels” to “full voxels”, resulting in a higher degree of confounding
by the partial volume effect. I would like to point out that partial
volume errror is considered to be troublesome only if cortical
thickness is less than 3 times the voxel size (29). Therefore, us-
ing a voxel size of 0.5 mm a cortical thickness greater than 1.5
mm allows for accurate assessment of cortical bone density and
CSA. In fact, cortical bone should be evaluated at radial diaph-
ysis, where the cortical thickness is greater than 1.9 mm or, bet-
ter, at the tibial diaphysis where the cortical bone was found to be
thicker than 3.0 mm in more than 90% of a representative Italian
population in which very old persons were oversampled (13, 14).
Indeed, in previous studies, information on cortical bone ob-
tained by pQCT at a correct anatomic site was a strong predic-
tor of bone mechanical resistance and fracture risk (see above)
(26, 30). Moreover, in some instances, a specific assessment
of cortical bone is critical for a correct evaluation of bone sta-
tus. For example, in hyperparathyroidism, in which the cortical
bone is specifically compromised, and in the follow-up of some
treatments specifically influencing cortical bone density and
thickness (e.g. teriparatide, anabolic agents), the assessment
either of trabecular bone parameters by pQCT or of the total
bone mass by DXA may be misleading (31).
From cortical bone vBMD and mass to whole bone geometry
assessment
Cortical bone vBMD: declines with age with a greater slope in
women than men, likely reflecting increasing porosity. Vitamin
D deficiency, with its attendant hyperparathyroidism, typically
reduces cortical vBMD with two mechanisms: reduced mineral-
ization of bone matrix, and increased intracortical porosity
through stimulation of bone remodeling. Reduced cortical vB-
MD is also found in other conditions characterized by in-
creased remodeling and rapid bone loss, such as hyperthy-
roidism. Therefore, a low value of this parameter may give an
important clinical clue to the presence of elevated bone remod-
eling and high circulating PTH or thyroid hormones levels.
Cortical bone CSA and the composite parameter cortical BMC
116 Clinical Cases in Mineral and Bone Metabolism 2005; 2(2): 113-118
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(Cortical CSA*cortical vBMD*slice thickness) are parameters
related to bone mass, which are strictly related to compressive
strength of the examined bone, exhibit a fast decline in older
women (after 60 years of age), and are greatly reduced in os-
teoporosis. Interestingly, in men cortical CSA and BMC are sta-
ble until old age at population level (13).
Cortical thickness: paralleling changes in cortical CSA and
BMC, cortical thickness declines in older women, not older
men. Age-associated changes in the parameters of bone bend-
ing and torsional stability (maximum, minimum, and polar mo-
ments of inertia) are strictly related to cortical thickness.
Total bone CSA: represents bone size and is a simple, yet very
important parameter related to both compressive and bending
strength. In fact, changes in total bone CSA, whether age-as-
sociated or following anabolic interventions, translate into sub-
stantial differences in compressive and bending strength.
Moments of inertia and the related parameters section moduli:
describe the resistance of a structure to bending loads (maxi-
mum and minimum moment of inertia) and torsional loads (po-
lar moment of inertia) and represent the most qualifying contri-
bution of pQCT toward comprehension of determinants of bone
strength. The (density-weighted) moment of inertia (also called
“Bone strength index”) is calculated by summing up the dis-
tance of all the voxels containing bone from the center of mass
(to the fourth power) multiplied by the density each voxel.
Therefore, in this calculation the distribution of bone material is
much more important than its amount. Section modulus de-
rives from moment of inertia multiplied by the maximum dis-
tance of the voxels from the center of mass and, therefore, it is
only relevant in non-cylindrical structures. It should be noted
that calculation of moments of inertia and section moduli are
not specific to the assessment of bone strength but, rather, are
the common modality employed by engineers to estimate resis-
tance of structures to bending and torsion (columns, buildings,
etc.). Moments of inertia, paralleling the other cortical bone pa-
rameters, decline in old age in women only (13, 14). Unravel-
ing the determinants of the observed sex-difference in age-as-
sociated changes in the above described cortical and whole
bone parameters is the key to understanding why older women
have a higher fracture risk than elderly men. 
Assessment of muscle CSA and muscle-bone relationship
by pQCT
Muscle CSA is an important determinant of muscle force, and
the latter is a strong determinant of bone mass and strength.
Therefore, assessing both muscle force and an indicator of
bone strength (such as bone strength index) in osteoporotic
patients may give useful information as to the cause of low
bone mass. Based on this premise, several groups have as-
sessed muscle CSA at forearm and calf by pQCT as a surro-
gate measure of muscle strength of the upper and lower limb,
respectively, and have evaluated the relationship between
muscle CSA and cortical bone CSA or moment of inertia at the
same site. As expected, a close relationship linked the muscle
and bone parameter both in children and in adults (R2 = 0.60-
0.95) (32). A few studies suggest that osteopenic states may
be further characterized by investigating the proportionality be-
tween muscle and bone mass. In fact, according to this view,
bone loss following a hypomobility condition associated with
sarcopenia would give origin to a “concordant” or “armonic” os-
teopenia, in which both muscle mass and bone mass are re-
duced and the ratio between them remains constant. On the
other hand, a bone loss caused by an endocrino-metabolic dis-
order, such as a “true” osteoporosis or hyperparathyroidism,
would lead to a “discordant” or “disarmonic” osteopenia, in
which muscle mass is preserved or is reduced to a lesser ex-
tent than bone mass. In one study osteoporotic patients with
fractures had a similar degree of osteopenia as age-matched
healthy postmenopausal women, however, in the fracture pa-
tients the ratio between tibia cortical CSA and muscle CSA at
the calf was reduced compared with the controls (33). Other
studies in children obtained similar results (34). These findings
raise the possibility of diagnosing patients with osteoporosis
and high fracture risk from osteopenic individuals whose low
bone mass is merely a consequence of frailty. Based on these
patho-physiological considerations, the mainstay of treatment
of these patients is an appropriate “sarcogenic” and “os-
teogenic” form of physical exercise, such as vibration training,
not an antiresorptive drug (35, 36).
Advantages and disadvantages of pQCT, compared to 
planar densitometry and axial QCT
Compared to conventional planar densitometry and axial QCT,
pQCT presents several practical and safety advantages, in-
cluding low space requirement and transportability of the de-
vice. Moreover, compared to axial QCT pQCT has a lower
cost, and much lower irradiation to operator and patient. Com-
pared with DXA, pQCT is more reliable since the availability of
cross-sectional images allows for immediate recognition of er-
rors due to incorrect positioning and movements of the pa-
tients. On the other hand, in DXA measurements an incorrect
positioning of the patient may be evident only at a follow-up ex-
amination, when differences in the BMD values are too high to
have a biological cause, or may never be appreciated if the
baseline and follow-up have consistent, albeit incorrect figures
(37). This often neglected source of inaccuracy and impreci-
sion in DXA measurements may influence the decision on
whether to begin or continue a treatment. 
However, the use of pQCT also has limitations. Among these,
a high level of dependence on the operator and the numerosity
and complexity of the parameters that can be obtained may
have prevented a wider use of this method in the clinical prac-
tice. Another limitation is the need to assess multiple sites in
order to “sample” the most suitable sources of information in
the skeleton. In my experience, radial metaphysis for trabecu-
lar bone and tibial diaphysis for cortical bone are the ideal sites
for obtaining thorough, accurate, and informative measure-
ments. An often cited limitation of pQCT is the lack of assess-
ment of the most common fracture sites (spine and hip). How-
ever, Colles fracture is a common osteoporotic fracture, which
often occurs many years before other osteoporotic fractures.
Moreover, age- and menopause-related bone loss usually oc-
curs at all skeletal sites, albeit at different rates, and osteo-
porosis is certainly a systemic condition. Consistently, periph-
eral bone mass measurements have been recently shown in
the NORA study to effectively predict bone loss and occur-
rence of osteoporotic fractures in both early postmenopausal
and older women (38). 
Conclusions
As shown in this review, compared to both DXA and axial QCT,
pQCT is a more versatile technique, allowing for selective as-
sessment of trabecular and cortical bone components, accu-
rate assessment of bone geometry, assessment of muscle
mass and muscle/bone relationships.
PQCT has not been evaluated as thoroughly as DXA in clinical
research; therefore the availability of normative data is scant
and mostly limited to trabecular vBMD. Likewise, prospective
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studies indicating prediction of fracture risk are needed in order
to develop recommendations on pQCT measurements in the
clinical practice. However, recent studies on representative
populations in the USA and Italy have yielded normative data
on trabecular and cortical bone vBMD, and geometry parame-
ters obtained by pQCT at multiple skeletal sites (13, 39).
In the Italian study tibial pQCT parameters have been obtained
in more than 1200 subjects spanning from 20 to 102 years of
age; these data could provisionally be used as reference val-
ues by physicians to detect patients with osteopenia, assess
their bone strength, and to plan appropriate, patho-physiologi-
cally based treatment (13, 14). 
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